Treatment of Gastroesophageal Junction Carcinoma
Ian Chau, MD, of Royal Marsden Hospital in London, reviews first- and second-line treatment options for patients with carcinoma of the gastroesophageal... Read More
Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer
New research from Bio Med Central shows down-regulated OPCML expression might serve as an independent predictor for gastric cancer prognosis.
Newly discovered cancer mutations could boost drug discovery
Scientists from the University of Maryland have identified thousands of genetic mutations that could contribute to cancer growth, including gastric cancer. Using... Read More
miRNA-34a enhances the sensitivity of gastric cancer cells to treatment with paclitaxel by targeting E2F5
A new study in Spandidos Publications shows micro RNA-34a, a tumor suppressor in various types of cancer, enhances the sensitivity of gastric... Read More
Neutrons identify critical details in bacterial enzyme implicated in gastric cancer
Neutron analysis is helping researchers better understand a key enzyme found in a bacterium known to cause gastric cancer. Understanding the details... Read More
MicroRNA-320 inhibits invasion and induces apoptosis by targeting CRKL and inhibiting ERK and AKT signaling in gastric cancer cells
MicroRNA-320 (miR-320) downregulation has been reported in several human cancers. Until now, its expression pattern and biological roles in human cancer remain... Read More
Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway
A new study found that luteolin significantly suppressed gastric cancer progression by inhibiting cell proliferation, migration, and invasion.
Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer
New research looks at GAP2–AS1 that’s upregulated by SP1 plays an important role in gastric cancer development and progression by suppressing P21... Read More
Timing of initiation of adjuvant chemotherapy for gastric cancer: A case-matched comparison study of laparoscopic vs. open surgery
Researchers seek to understand the influence of the surgical approach on initiation of adjuvant chemotherapy for gastric cancer.
Dr. Ahn on Neoadjuvant Treatments for Patients With Gastric Cancer
Dr. Daniel H. Ahn with the Mayo Clinic discusses advances in neoadjuvant therapies for patients with gastric cancer during the 2017 OncLive... Read More
